Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jung-Mi Hah

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Biomedicines|October 23, 2021
A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking StudiesHyunwook Cho, Jung-Mi Hah
Archives of Pharmacal Research|September 8, 2025
Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosisSwapnil P Bhujbal, Jung-Mi Hah
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent InhibitorsSwapnil P Bhujbal, Jung-Mi Hah
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site ComparisonSwapnil P Bhujbal, Jung-Mi Hah
International Journal of Molecular Sciences|December 10, 2021
Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR ApproachSwapnil P Bhujbal, Jung-Mi Hah
Bioorganic & Medicinal Chemistry Letters|April 5, 2017
Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitorsHoyong Jung, Waqar Aman, Jung-Mi Hah
Chemistry, an Asian Journal|February 26, 2015
De Novo Design and Synthesis of a γ-Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric LigandMi-Hyun Kim, Junghun Lee, Jung-Mi Hah
Molecules (Basel, Switzerland)|October 14, 2022
Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR StudiesSwapnil P Bhujbal, Weijie He, Jung-Mi Hah
Journal of the American Chemical Society|July 23, 2008
Light-mediated liberation of enzymatic activity: "small molecule" caged protein equivalentsHaishan Li, Jung-Mi Hah, David S Lawrence
Archives of Pharmacal Research|October 7, 2011
A python-based docking program utilizing a receptor bound ligand shape: PythDockJae Yoon Chung, Seung Joo Cho, Jung-Mi Hah
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Biomedicines|October 23, 2021
A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking StudiesHyunwook Cho, Jung-Mi Hah
Archives of Pharmacal Research|September 8, 2025
Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosisSwapnil P Bhujbal, Jung-Mi Hah
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent InhibitorsSwapnil P Bhujbal, Jung-Mi Hah
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site ComparisonSwapnil P Bhujbal, Jung-Mi Hah
International Journal of Molecular Sciences|December 10, 2021
Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR ApproachSwapnil P Bhujbal, Jung-Mi Hah
Bioorganic & Medicinal Chemistry Letters|April 5, 2017
Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitorsHoyong Jung, Waqar Aman, Jung-Mi Hah
Chemistry, an Asian Journal|February 26, 2015
De Novo Design and Synthesis of a γ-Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric LigandMi-Hyun Kim, Junghun Lee, Jung-Mi Hah
Molecules (Basel, Switzerland)|October 14, 2022
Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR StudiesSwapnil P Bhujbal, Weijie He, Jung-Mi Hah
Journal of the American Chemical Society|July 23, 2008
Light-mediated liberation of enzymatic activity: "small molecule" caged protein equivalentsHaishan Li, Jung-Mi Hah, David S Lawrence
Archives of Pharmacal Research|October 7, 2011
A python-based docking program utilizing a receptor bound ligand shape: PythDockJae Yoon Chung, Seung Joo Cho, Jung-Mi Hah
Pageof 6